Science Valley Research Institute
Santo Andre, Sao Paulo, Brazil
Eduardo Ramacciotti, MD, MHS, Ph.D
Head, Cardiovascular Medicine, HMCG DASA, SP, Brazil
Professor, Thrombosis and Hemostasis, Loyola University Medical Center, Chicago, IL, USA
CMO Science Valley Research Institute, SP, Brazil
Dr Ramacciotti is the CBO of Science Valley Research Institute, a private CTO in São Paulo, Brazil. He is a professor of vascular surgery at Santa Casa School of Medicine, São Paulo, Brazil. He is a visiting professor at the Loyola University Medical Center (Chicago, USA) with the affiliation of the Departments of Pathology and Pharmacology. He has extensive expertise in the cardiovascular area, focusing on thrombosis, hemostasis, peripheral artery diseases, and drug development. Dr. Ramacciotti is a clinical trialist, and mentors graduate students to Ph.D. programs. His clinical background includes MD, MPH, and PhD degrees, with 2 fellowship programs (post-doc), including basic and clinical research at the University of Michigan and Loyola University Medical Center, Chicago, USA. His strong publication background includes 105 major papers published, 4 book chapters, and major oral presentations. He received a 2009 US national award for innovative vascular research in VTE and a 2009 Global award from the IUA – best research of the year. In 2017 Dr Ramacciotti was given the Outstanding Achievement award by the NATF / GTF for his contributions to education. His employment included Global Medical Leading director of Bristol Myers Co R&D in New York from 2010-2014, a direction of basic to late phase clinical research in cardiovascular areas, including the oral anticoagulant apixaban. He has also been involved in the clinical validation of the effect of heparins in VTE and similar indications. He has carried out innovative research in the management of cancer-associated thrombosis. He serves as an Editor to several journals in vascular surgery and is on the advisory board of international courses for vascular specialists.
SOA 10.1 - The Latest on Anticoagulant Management of COVID-19
Monday, June 26, 2023
08:00 – 08:25 ET